Equity Capital Markets

Company · CIK 1540171

Avalyn Pharma Inc.

CIK1540171 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressMA
ListedAVLN (Nasdaq)
First annual or quarterly report2026-06-03

Offerings

1 registration
RegistrationLabel and statusFirst filedLast eventFilings
333-294932
IPOFinal prospectus
 2026-04-082026-04-305

Filings

6
FiledFilingRegistrationAccession
2026-04-30424B4Final prospectus 333-2949320001193125-26-197686
2026-04-29EFFECTDeclared effective 333-2949329999999995-26-001383
2026-04-29S-1/AAmendment 333-2949320001193125-26-189477
2026-04-23S-1/AAmendment 333-2949320001193125-26-173632
2026-04-08S-1Registration filed 333-2949320001193125-26-147573
2026-02-06DRSDraft made public 377-090140001193125-26-040979

All filings of this company · CSV